Targeted antigen delivery by an anti-class II MHC VHH elicits focused αMUC1(Tn) immunity

Structurally Defined αMHC-II Nanobody-Drug Conjugates: A Therapeutic and Imaging System for B-Cell Lymphoma

(2016) Tao Fang et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Distinct antibody species: structural differences creating therapeutic opportunities

(2016) Serge Muyldermans et al.   CURRENT OPINION IN IMMUNOLOGY

Generation of Immunity against Pathogens via Single-Domain Antibody–Antigen Constructs

(2016) Joao N. Duarte et al.   JOURNAL OF IMMUNOLOGY

Mucin architecture behind the immune response: design, evaluation and conformational analysis of an antitumor vaccine derived from an unnatural MUC1 fragment

(2016) Nuria Martínez-Sáez et al.   Chemical Science

Guiding Principles in the Design of Molecular Bioconjugates for Vaccine Applications

(2015) Haipeng Liu et al.   BIOCONJUGATE CHEMISTRY

Noninvasive imaging of immune responses

(2015) Mohammad Rashidian et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Covalent Bond or Noncovalent Bond: A Supramolecular Strategy for the Construction of Chemically Synthesized Vaccines

(2014) Yue Gao et al.   CHEMISTRY-A EUROPEAN JOURNAL

Nanobody–photosensitizer conjugates for targeted photodynamic therapy

(2014) Raimond Heukers et al.   Nanomedicine-Nanotechnology Biology and Medicine

Self-Adjuvanting Synthetic Antitumor Vaccines from MUC1 Glycopeptides Conjugated to T-Cell Epitopes from Tetanus Toxoid

(2013) Hui Cai et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Dendritic-Cell-Based Therapeutic Cancer Vaccines

(2013) Karolina Palucka et al.   IMMUNITY

Sortase-mediated modification of αDEC205 affords optimization of antigen presentation and immunization against a set of viral epitopes

(2013) Lee Kim Swee et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

MUC1 Vaccine for Individuals with Advanced Adenoma of the Colon: A Cancer Immunoprevention Feasibility Study

(2012) T. Kimura et al.   Cancer Prevention Research

MUC1 immunotherapy is here to stay

(2012) Takashi Kimura et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

a Totally Synthetic, Self-Assembling, Adjuvant-Free MUC1 Glycopeptide Vaccine for Cancer Therapy

(2012) Zhi-Hua Huang et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Preparation of unnatural N-to-N and C-to-C protein fusions

(2012) Martin D. Witte et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Clinical Impact of Different Classes of Infiltrating T Cytotoxic and Helper Cells (Th1, Th2, Treg, Th17) in Patients with Colorectal Cancer

(2011) Marie Tosolini et al.   CANCER RESEARCH

Synthetic, Structural, and Biosynthetic Studies of an Unusual Phospho-Glycopeptide Derived from α-Dystroglycan

(2011) Kai-For Mo et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design

(2011) Fikri Y Avci et al.   NATURE MEDICINE

Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine

(2011) V. Lakshminarayanan et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Sortase-catalyzed transformations that improve the properties of cytokines

(2011) M. W. Popp et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Boosting antibody responses by targeting antigens to dendritic cells

(2011) Irina Caminschi et al.   TRENDS IN IMMUNOLOGY

Flow cytometry-based assay to evaluate human serum MUC1-Tn antibodies

(2010) Catharina H.M.J. Van Elssen et al.   JOURNAL OF IMMUNOLOGICAL METHODS

The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research

(2009) M. A. Cheever et al.   CLINICAL CANCER RESEARCH

Modulation of protein properties in living cells using nanobodies

(2009) Axel Kirchhofer et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

Human Tumor Antigens Tn and Sialyl Tn Arise from Mutations in Cosmc

(2008) T. Ju et al.   CANCER RESEARCH

CD11c provides an effective immunotarget for the generation of both CD4 and CD8 T cell responses

(2008) Fernanda V. V. Castro et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

General Strategy to Humanize a Camelid Single-domain Antibody and Identification of a Universal Humanized Nanobody Scaffold

(2008) Cécile Vincke et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Structure and Function of the Cell Surface (Tethered) Mucins

(2007) Christine L. Hattrup et al.   Annual Review of Physiology